NAVITAS: A Study to Characterize the Relationship Between Select Objective Metrics and Clinical Outcomes in Chronic Pain Patients Treated With Boston Scientific Neurostimulation Systems
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/12/2018 |
Start Date: | July 31, 2017 |
End Date: | December 31, 2023 |
Contact: | Ann Masuda |
Email: | Ann.Masuda@bsci.com |
Phone: | 661-949-4726 |
The objective of the study is to characterize the relationship between select objective
metrics and clinical outcomes in chronic pain patients treated with Boston Scientific
commercially approved neurostimulation systems.
metrics and clinical outcomes in chronic pain patients treated with Boston Scientific
commercially approved neurostimulation systems.
Key Inclusion Criteria:
- Is enrolled in the Boston Scientific RELIEF study
- Is willing and able to comply with completing protocol required assessments and
evaluations
- Has an average overall pain intensity of 5 or greater on a 0-10 numerical rating scale
at RELIEF primary protocol Baseline Visit
Key Exclusion Criteria:
- Has any pain-related diagnosis, medical/psychological condition or external factors
that, in the investigator's medical judgment, might confound reporting of study
outcomes (e.g. history of pelvic pain, anginal pain, chronic migraine, involved in
litigation, workmen's compensation)
We found this trial at
1
site
Valencia, California 91355
Phone: 855-213-9890
Click here to add this to my saved trials